McKinsey & Co. has paid more than $1 billion to resolve government claims over consulting work that allegedly helped Purdue Pharma boost sales of OxyContin. Now, plaintiffs still pursuing claims against McKinsey over the opioid crisis want to examine the consulting giant's relationship with Johnson & Johnson.
At a hearing Monday, plaintiffs represented by West Virginia attorney Stephen P. New and lawyers from Lieff Cabraser Heimann & Bernstein LLP asked U.S. Magist...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In



